AAA
KDNY
Affinity Asset Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-321,017
| Closed | -$12.3M | – | 88 |
|
|
2023
Q2 | $12.3M | Sell |
321,017
-655,004
| -67% | -$25.2M | 4.31% | 4 |
|
|
2023
Q1 | $22.6M | Buy |
976,021
+157,986
| +19% | +$3.66M | 7.46% | 1 |
|
|
2022
Q4 | $21.4M | Buy |
818,035
+4,037
| +0.5% | +$106K | 8.41% | 1 |
|
|
2022
Q3 | $16M | Sell |
813,998
-123,570
| -13% | -$2.43M | 4.47% | 2 |
|
|
2022
Q2 | $16.4M | Buy |
937,568
+92,413
| +11% | +$1.62M | 6.91% | 3 |
|
|
2022
Q1 | $13.8M | Buy |
845,155
+290,000
| +52% | +$4.74M | 2.21% | 6 |
|
|
2021
Q4 | $9.06M | Buy |
555,155
+480,814
| +647% | +$7.84M | 3.29% | 7 |
|
|
2021
Q3 | $949K | Sell |
74,341
-125,659
| -63% | -$1.6M | 0.24% | 53 |
|
|
2021
Q2 | $2.82M | Buy |
200,000
+25,000
| +14% | +$353K | 1.01% | 19 |
|
|
2021
Q1 | $2.72M | Buy |
175,000
+25,000
| +17% | +$389K | 0.92% | 22 |
|
|
2020
Q4 | $2.38M | Buy |
+150,000
| New | +$2.38M | 1.26% | 18 |
|